Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

56 results about "Statistical difference" patented technology

Statistical difference refers to significant differences between groups of objects or people. Scientists calculate this difference in order to determine whether the data from an experiment is reliable before drawing conclusions and publishing results.When studying the relationship between two variables, scientists use the chi-square calculation method.

No-reference video quality evaluation method based on space-time domain natural scene statistics characteristics

Objective video quality evaluation is one of the important research points for QoE service in the further. The invention provides a video quality evaluation method based on no-reference natural scene statistics (NSS). Firstly, through analyzing a video sequence, corresponding statistical values of each pixel point and the adjacent point are calculated and space domain statistics characteristics of the video are thus obtained. A predication image of an n+1 frame is obtained according to a motion vector and in combination with a reference frame n, a motion residual image is obtained, and statistical distribution after DCT transformation is carried out on the residual image is observed. Values obtained in the former two steps are used for respectively calculating a mahalanobis distance between the space domain characteristics and the natural video characteristics and a mahalanobis distance between the time domain characteristics and the natural video characteristics so as to obtain statistical differences between a distorted video and the natural video, and the quality of a single-frame image is obtained when the time domain information and the space domain information are converged. Finally, a time domain aggregation strategy on the basis of visual hysteresis effects is adopted to obtain the objective quality of the final video sequence.
Owner:BEIJING UNIV OF POSTS & TELECOMM

Alzheimer's disease cortex auto-classification method based on multi-scale mesh surface form features

ActiveCN104102839AAvoid detrimental effects of segmentation accuracyImprove reliabilitySpecial data processing applicationsTest performanceVertex point
The invention discloses an Alzheimer's disease cortex auto-classification method based on multi-scale mesh surface form features. The method includes the steps of determining two sample groups, namely an AD (Alzheimer's disease) group and an NC (normal control) group, and dividing the sample groups into a sample set and a test set under equal proportion; extracting multi-scale mesh surfaces from brain MRI (magnetic resonance imaging) images of samples; calculating LVPD (local vertex point distance) and average curvature for each vertex; with the smoothed LVPD and average curvature, extracting areas having a significant statistical difference and screening two seed points in index sense; extracting a feature row vector for each sample of the training set to form a feature matrix, and training a classifier with the reduced dimensionality feature matrix and corresponding sample classes; testing performance of the classifier with the samples in the test set. By the use of the Alzheimer's disease cortex auto-classification method based on multi-scale mesh surface form features, the defects the prior art is susceptible to cortex segmentation errors and certain-scale difference may be missed are overcome, and the two sample groups can be classified according to the cortex multi-scale form features.
Owner:XIDIAN UNIV

Implementation method for identifying motion models based on cerebral-cortex hemoglobin information

ActiveCN104771255ASolve psychological problemsAddress ethical issuesDiagnostic recording/measuringSensorsHuman bodyRelative motion
The invention discloses an implementation method for identifying motion models based on cerebral-cortex hemoglobin information. A testee self-controls the starting and stopping time under four motion models; as for the change rate of cerebral-cortex hemoglobin concentration, the statistical analysis technique is adopted to analyze the statistical difference between oxyhaemoglobin and deoxyhemoglobin in various motion related areas of the cerebral cortex under different motion models, and based on the statistical characteristics, two relative motion trends of getting-up and sitting-down, as well as stair ascending and descending, are distinguished; and on this basis, the difference between oxyhaemoglobin and deoxyhemoglobin in various motion areas of the cerebral cortex is analyzed, together with the both-leg relative motion trends and the new statistical characteristics, the specific motion model is distinguished. The non-intrusive NIRS technology is adopted to record the cerebral-cortex hemoglobin concentration information of a human body without external stimulation or preliminary training, and restrictions on the test environment and the testee are less; the advantage of ideal time and space resolution is achieved; and the intelligence of walking aids is improved.
Owner:SUZHOU UNIV

Method for quantitatively discriminating nephrite production areas

The invention provides a method for quantitatively discriminating nephrite production areas. The method includes the steps that firstly, nephrite samples of known production areas are prepared; secondly, the content of microelements of the samples is quantitatively tested, and test points are divided into a training group and a testing group; thirdly, the content of the microelements is subjected to significance level analysis to detect whether statistic differences exist between different production areas; fourthly, by means of the binary iteration linear discriminant analysis (IB-LDA) method, data of the training group are discriminated two by two, and feasibility of the method is tested through the testing group; fifthly, the production areas of the samples to be tested are predicted through the IB-LDA method. The method quantitatively discriminates the nephrite production areas on the basis of binary iteration linear discriminant analysis of the microelements, the mode that multiple traditional groups are compared at the same time is simplified into the mode that the groups are compared two by two, and the discrimination probability of each production area relative to other production area is obtained. Besides, the discrimination ability of a discrimination function is remarkably improved. Compared with the naked eye qualitative discrimination method and a traditional linear discriminant analysis method, the method has obvious advantages.
Owner:CHINA UNIV OF GEOSCIENCES (WUHAN)

High-order aberration compensation method for corneal refractive correction

The invention provides a high-order aberration compensation method for corneal refractive correction. The compensation method is used for solving the problem that high-order aberration compensation methods in the prior art cannot meet requirements and comprises the steps that according to a wavefront fitting function of C7 and C8, the concave-sphere amount, astigmatism amount and the astigmatism angle after compensation of C7 and C8 are calculated; according to a wavefront fitting function of C12, the concave-sphere amount after compensation of C7, C8 and C12 is calculated; according to a wavefront fitting function of C11 and C13, the concave-sphere amount, astigmatism amount and the astigmatism angle after compensation of C7, C8, C11 and C12 are calculated. According to the method, a representation method of a Zernike polynomial and the low-order aberration diopter are converted, and the unit is unified; the comatic aberration, spherical aberration and second-order astigmatism are subjected to conversion of a qualitative and quantitative relationship, the high-order aberration for the corneal refractive correction of the human eyes is better compensated for, the compensation accuracy is improved, the better visual quality is obtained, and meanwhile the statistical difference is taken into account.
Owner:杭州明视康眼科医院有限公司

Application of tanshinone II A in preparing medicine for curing tendon adhesion

The invention discloses application of tanshinone II A in preparing medicine for curing tendon adhesion, and belongs to the technical field of medicine. After a heel tendon adhesion rat model is manufactured, tanshinone II A sulfonic acid natrium local injection is carried out on heel tendon of the heel tendon adhesion rat model, and the heel tendon adhesion conditions are compared through a contrast to a blank group, and a histological observation and a statistical analysis are carried out. The result shows that in a general observation, the heel tendon adhesion of a salvia miltiorrhiza group is less than that of the blank group, and p is less than 0.05, and statistical difference exists; in the histological observation, the quantities of collagenous fiber and fibroblasts of the salvia miltiorrhiza group are increased by comparing with common heel tendon tissue; the arrangement is relatively regular; the quantities of collagenous fiber and fibroblasts of the blank group are obviously increased, and the arrangement is irregular; The Real-time PCR found that the expression of TGF(transforming growth factor)-beta 1 of the salvia miltiorrhiza group is obviously reduced relative to that of the blank group. The results show that the tanshinone II A has the function of inhibiting the generation and development of tendon adhesion, and can be used for preparing medicine for curing tendon adhesion.
Owner:THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE

Application of indomethacin in preparation of drugs for preventing and treating cancers

The invention relates to application of indomethacin in preparation of drugs for preventing and treating cancers. Molecular formula of the indomethacin is C19H16ClNO4 and molecular weight of the indomethacin is 357.79. Significant effects of indomethacin on prevention of an esophagus cancer in a humanized transplantation tumor model (PDX) and a breast cancer in a mouse 4T1 breast cancer cell line transplanted model are verified. According to the application of the indomethacin in the preparation of the drugs for preventing and treating the cancers, the indomethacin is used for treating a humanized esophagus cancer tumor and a breast cancer cell transplantation mouse correspondingly, and when gross tumor volume of a control group is up to 1500 cubic millimeters or above, a test is finished. Test discoveries are that: compared with the control group, the gross tumor volume of the indomethacin-treated mice is significantly smaller, and a significant statistical difference is existent, indicating that the indomethacin has significant effects on preventing the esophagus cancer and the breast cancer. The esophagus cancer and the breast cancer can be prevented and treated clinically by taking the indomethacin by patients.
Owner:CHINA-US (HENAN) HORMEL CANCER INST

Implementation method of preventing and treating thrombus with black fungus

The invention discloses an implementation method of preventing and treating thrombus with black fungus. The implementation method comprises following steps: (1) soaking 500g of the black fungus in cold water; (2) crushing the black fungus through a pulverizer and extracting black fungus polysaccharide from the black fungus in a water-soluble manner or a lipid-soluble manner; (3) feeding experimental rabbits with each experimental black fungus polysaccharide component in equal amount for 2 months in an intragastric administration manner; (4) observing physical indexes of the experimental rabbits in vitro; (5) performing statistical analysis to the physical indexes of the experimental rabbits with results being all represented as (x+/-S), wherein a t-test method is employed for comparison among groups and a statistical difference exists with P<0.05. The method, by means of the black fungus polysaccharide in the black fungus, can prolong a forming time of New Zealand rabbit specific thrombus and fibrous protein thrombus, reduce in-vitro thrombus length and reduce wet weight and dry weight of the thrombus, can reduce platelet adhesiveness rate and blood viscosity, can significantly reduce a dissolving time of euglobulin, can reduce plasma fibrinogen content, can increase plasmin activity and has significant thrombus forming resistance.
Owner:上海市建青实验学校

A kind of gear box composite fault component separation diagnosis method and device

The invention discloses a method and a device for separating and diagnosing components of a composite fault of a gearbox. Starting from the typical failure modes of the main components of the gearbox and gears, combined with the convolution sparse theory, a multi-scale composite regularization convolution sparse separation diagnosis algorithm is proposed. Separation of linear aliasing and coupled composite faults. According to the fault dynamics difference between bearings and gears, the idea of ​​multi-scale convolution kernel is proposed to better match the fault components. A composite regularization sparse model is proposed for the statistical differences of each component in the composite fault signal. The optimization problem of the model is transformed into the frequency domain to realize the fusion solution of multi-scale convolution kernels, and the frequency domain optimization problem is decomposed into sub-problems alternately iteratively solved by using the alternate iterative solution framework in the alternating direction multiplier method. The experiment verifies the effectiveness of the method. Feasibility and effectiveness. Effective separation and diagnosis of compound faults are realized, and Gaussian noise and slowly varying harmonic interference are avoided.
Owner:XI AN JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products